Comment on: Recombinant human TSH in differentiated thyroid cancer: a nuclear medicine perspective

被引:2
|
作者
Luster, Markus [1 ]
Schlumberger, Martin [2 ]
Pacini, Furio [3 ]
机构
[1] Univ Ulm, Dept Nucl Med, D-89081 Ulm, Germany
[2] Inst Gustave Roussy, Dept Nucl Med & Endocrine Oncol, F-94805 Villejuif, France
[3] Univ Siena, Sect Endocrinol & Metab, Dept Internal Med, I-53100 Siena, Italy
关键词
HORMONE WITHDRAWAL; RADIOIODINE THERAPY; MANAGEMENT; CARCINOMA; DOSIMETRY; ABLATION;
D O I
10.1007/s00259-008-1013-9
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
引用
收藏
页码:329 / 330
页数:2
相关论文
共 50 条
  • [21] Recombinant human thyrotropin (rhTSH) aided radioiodine treatment for residual or metastatic differentiated thyroid cancer
    Ma, Chao
    Xie, Jiawei
    Liu, Wanxia
    Wang, Guoming
    Zuo, Shuyao
    Wang, Xufu
    Wu, Fengyu
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2010, (11):
  • [22] Appropriate Use Criteria for Nuclear Medicine in the Evaluation and Treatment of Differentiated Thyroid Cancer
    Donohoe, Kevin J.
    Aloff, Jennifer
    Avram, Anca M.
    Bennet, K. G.
    Giovanella, Luca
    Greenspan, Bennett
    Gulec, Seza
    Hassan, Aamna
    Kloos, Richard T.
    Solorzano, Carmen C.
    Stack, Brendan C., Jr.
    Tulchinsky, Mark
    Tuttle, Robert Michael
    Van Nostrand, Douglas
    Wexler, Jason A.
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61 (03) : 375 - 396
  • [23] Higher TSH level is a risk factor for differentiated thyroid cancer
    Kim, Hee Kyung
    Yoon, Jee Hee
    Kim, Soo Jeong
    Cho, Jin Seong
    Kweon, Sun-Seog
    Kang, Ho-Cheol
    CLINICAL ENDOCRINOLOGY, 2013, 78 (03) : 472 - 477
  • [24] Recombinant human thyrotropin preparation for adjuvant radioiodine treatment in children and adolescents with differentiated thyroid cancer
    Handkiewicz-Junak, Daria
    Gawlik, Tomasz
    Rozkosz, Jozef
    Puch, Zbigniew
    Michalik, Barbara
    Gubala, Elzbieta
    Krajewska, Jolanta
    Kluczewska, Aneta
    Jarzab, Barbara
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2015, 173 (06) : 873 - 881
  • [25] An elevated level of TSH might be predictive of differentiated thyroid cancer
    Dorange, Anne
    Triau, Stephane
    Mucci-Hennekinne, Stephanie
    Bizon, Alain
    Laboureau-Soares, Sandrine
    Illouz, Frederic
    Rodien, Patrice
    Rohmer, Vincent
    ANNALES D ENDOCRINOLOGIE, 2011, 72 (06) : 513 - 521
  • [26] Recombinant Human Thyroid-Stimulating Hormone Versus Thyroid Hormone Withdrawal in 124I PET/CT-Based Dosimetry for 131I Therapy of Metastatic Differentiated Thyroid Cancer
    Plyku, Donika
    Hobbs, Robert F.
    Huang, Kevin
    Atkins, Frank
    Garcia, Carlos
    Sgouros, George
    Van Nostrand, Douglas
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58 (07) : 1146 - 1154
  • [27] Recombinant human TSH-aided radioiodine treatment of advanced differentiated thyroid carcinoma: a single-centre study of 54 patients
    Jarzab, B
    Handkiewicz-Junak, D
    Roskosz, J
    Puch, Z
    Wygoda, Z
    Kukulska, A
    Jurecka-Lubieniecka, B
    Hasse-Lazar, K
    Turska, M
    Zajusz, A
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2003, 30 (08) : 1077 - 1086
  • [28] Can the basal serum thyroglobulin level be used to predict the recombinant human TSH-stimulated thyroglobulin level in differentiated patients with thyroid cancer?
    Jeong, Eugene
    Yoon, Joon-Kee
    Lee, Su Jin
    Soh, Euy Young
    Lee, Jeonghun
    Kim, Hyeung Kyoo
    An, Young-Sil
    MEDICINE, 2019, 98 (51)
  • [29] Recombinant Human TSH Increases Uptake and Effective Half-life of Radioiodine in Thyroid Hormone Secreting Metastases of Follicular Thyroid Cancer
    Schneider, C.
    Dietlein, M.
    Eschner, W.
    Schmidt, M.
    Kahraman, D.
    Kobe, C.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2012, 120 (03) : 160 - 163
  • [30] Reduced insulin sensitivity in differentiated thyroid cancer patients with suppressed TSH
    De Melo, Thais Gomes
    Souza, Aglecio Luiz
    Ficher, Elizabeth
    Fernandes, Arlete Maria
    Montali Da Assumpcao, Ligia Vera
    Alegre, Sarah Monte
    Zantut-Wittmann, Denise Engelbrecht
    ENDOCRINE RESEARCH, 2018, 43 (02) : 73 - 79